Autistic Spectrum Disorders
and Mental & Behavioural Disorders
10am – 1pm
- Dr. Liz Mumper - Autistic Spectrum Disorders
- Dr. Mary Megson - Autistic Spectrum Disorders
- Dr. Judith Bowman - Walsh/Pfeiffer Autism
- Q & A Panel of Doctors
2pm – 5pm
Download Outreach Conference Brochure & Booking Form
- Dr Stephanie Fryar-Williams - Genetics and Epigenetics of Psychiatric Disorders
- Dr. William Walsh - Mental Health and Behavioural Disorders
- Q & A Panel of Doctors
||Sunday 20th March 2016
||Mantra on View, 22 View Avenue, Surfers Paradise (Gold Coast) Qld 4217 See Map
||Bio-Balance Health Association Inc.
||Professionals - $110.00 AUD inc GST
Parents & Public - $55.00 AUD inc GST
Patients - $10.00 AUD inc GST
$10 concession fee only for Patients who have booked a one hour assessment at the 2016 Outreach
||Click here to Book Online
Email Bookings: email@example.com
or phone bookings: 0475 910 513
Dr Mary N Megson, MD
Dr. Megson is a Developmental Paediatrician who has worked in the field of Paediatrics for more than twenty years.
As a developmental specialist in paediatrics, she devotes her career to children with developmental issues including ADHD, ADD, Autistic Spectrum Disorder, Asperger's Syndrome, Developmental Delays, etc.
Dr. Megson's areas of professional interest include Behavioural Paediatrics and Child Development. She is board certified by the American Board of Paediatrics and a member of the Society of Developmental Paediatrics.
Dr. Megson's research area is use of Vitamin A and Bethanecol in treatment of Autism Spectrum Disorders. She believes that autism is caused by a sequence of environmental events in genetically vulnerable children.
Dr. Megson is currently investigating the hypothesis that G-alpha protein defects are a high-risk factor for developing autism after vaccination. Her clinical trial of 60 children suggests that inserting a G-alpha protein defect - the pertussis toxin found in DTaP vaccine - into genetically at-risk children may be a cause of autism. Recently she has studied how changes in cell signalling may lead to autism, by looking at the gene profiles in over 1000 affected children. She discovered “snps” involving protein signaling in over half of these children.
Dr. Megson has also been speaking on the care of children as they grow up with autism into teens and adults as many of her patients are now graduating, working and/or going to college. These children are doing quite well with the right support.
Dr. Megson is credited with the largest number of recovered autistic patients in the USA DAN® Conference. Her work with autistic children is featured in the documentary film Beautiful Son.
Visit Dr. Megson's website at www.megson.com
Dr Elizabeth Mumper, M.D., FAAP
Dr. Mumper is President and CEO of Advocates for Children and Advocates for Families and founder of The RIMLAND Center (for mentoring clinicians interested in learning an integrative medicine approach to helping children with neurodevelopmental disorders such as autism, attention problems and learning differences). She graduated magna cum laude from Bridgewater College, where her mother worked, and her father taught history. She attended the Medical College of Virginia, did residency training at the University of Massachusetts and University of Virginia, and was invited to serve as Chief Resident of Paediatrics at UVA.
Dr. Mumper spent five years in practice at Hopkins Paediatrics. She spent over a decade as Director of Pediatric Education at the Lynchburg Family Practice Residency Program. She has just finished five years as the Medical Director of the Autism Research Institute.
Dr. Mumper has been honoured to receive many awards over the years, including being named a Miracle Maker in Central Virginia in 1996 by the Children’s Miracle Network and Woman of the Year in Health and Sciences in 1998 by the YWCA. She was privileged to accept a national award for corporate public service at the National Press Club in Washington on behalf of the Bike Helmet Safety Campaign she co-chaired for many years.
Dr. Mumper has written book chapters about allergy, immunology and behavioural and developmental paediatrics published in the book “Paediatrics”, a board review series book for medical students. She has published several research papers related to autism in the peer reviewed medical literature.
Dr. Mumper struggles to balance her roles as paediatrician, medical educator and writer with her joys and responsibilities as a wife and mother of two children. She loves to travel and teach.
Visit The Rimland Center's Website
Dr Judith Bowman, M.D.
Dr. Judith Bowman, a specialist in biochemical imbalances, received her B.A. from Illinois Wesleyan University in Biology-Pre-Med. She received her certification and licensure by the American Registry of Radiologic Technology and Board Certification in Nuclear Medicine Technology following the completion of her training at Northwestern University’s School of Nuclear Medicine. She utilised her skills in diagnostic imaging and participated in research and development of radiopharmaceuticals used therein. Dr. Bowman matriculated to The Chicago Medical School, completed her residency at Resurrection Hospital in Chicago in the field of Family Medicine and honed her managerial skills serving as chief resident physician in her final year.
Dr. Bowman served the Lake County Health Department in Illinois specialising in Women’s Health for 8 years. A stint at The Dore Achievement Center in Schaumburg, IL, focusing on innovative therapies for ADD and ADHD patients followed. She further engaged other behavioural disorders such as autism by working at the Pfeiffer Treatment Center (now closed) under the auspices of Dr. William Walsh, Ph.D. (Founder of the Pfeiffer Treatment Center (now closed)).
Dr. Bowman co-founded Mensah Medical located in Naperville, IL, in 2008 with her colleague (Dr. Albert Mensah). Here she combines traditional medicine with the biochemical approach to treat behavioural and cognitive disorders in a more comprehensive fashion.
Dr Stephanie Fryar-Williams MB BS BSc (Biochem/Phrmacol) FRANZCP
Dr Stephanie Fryar-Williams MB BS BSc (Biochem/Phrmacol) FRANZCP, is a neuro-psychiatrist with biochemistry qualifications. She is an Honoury Research Fellow at the University of Adelaide and Director of Youth-In-Mind Research Institute, South Australia. She holds accreditation in Child and Adolescent Psychiatry. In 2010, Dr Fryar-Williams teamed up with Dr. Jorg Strobel and Natasha Radcliffe (MHumNutr) to undertake the Mental Health Biomarker Project, via Basil Hetzel Institute for Translational Health Research and the Queen Elizabeth Hospital, Woodville South Australia. This published research discovered 21 biomarkers for Schizophrenia and psychosis, allowing formation of a predictive test for diagnosis and management of schizophrenia and schizoaffective psychosis.
Dr William J Walsh, PhD
Dr. Walsh is a scientist with over 40 years of research experience. He holds a doctorate in Chemical Engineering from Iowa State University. Dr. Walsh’s prison volunteer work during his career at Argonne National Laboratory led to studies of biochemical predisposition to behaviour disorders and crime, and collaboration with the renowned Dr. Carl Pfeiffer of Princeton, New Jersey. Dr. Walsh founded the Health Research Institute in 1982 and the Pfeiffer Treatment Center (now closed) (HRI-PTC) in Illinois in 1989.
He is Founder and President of the Walsh Research Institute, a public charity in Naperville, Illinois. His present activities include an International Physician Training Program and research in the areas of schizophrenia, autism, and behaviour disorders. He has trained more than 65 physicians in Australia and Norway and has the goal of training more than 1,000 doctors throughout the world. Dr. Walsh is preparing a major book on biochemical therapy that will include his new theory for the underlying cause of schizophrenia and an advanced approach for treatment of autism spectrum disorders. Other chapters will describe chemical imbalances associated with depression, behaviour disorders, ADHD, and Alzheimer’s Disease, and advanced nutrient therapies aimed at normalizing brain chemistry. Dr. Walsh’s book is expected to be published in 2011.
“Dr. Walsh is preparing a major book on biochemical therapy that will include his new theory for the underlying cause of schizophrenia and an advanced approach for treatment of autism spectrum disorders.”
Dr. Walsh has studied more than 30,000 patients with mental, behavioural and autistic disorders and developed a database of more than 3 million chemical assays of blood, urine and tissues that has been a valuable research tool. His recent research accomplishments include (a) the 1999 discovery of undermethylation and copper/zinc imbalances in autism; (b) the 2000 finding of metallothionein protein depletion in autism; (c) a 2004 published study linking copper overload and post-partum depression; (d) 2003 identification of oxidative stress as the primary autism trigger; and (e) a forensic study of Beethoven’s relics that revealed that the composer suffered from severe lead poisoning.
Dr. Walsh has authored more than 200 research reports and journal articles, has received 6 U.S. Patents and has been a speaker at 30 international conferences. He has received many awards including the 2002 Lighthouse Award from the Safe Harbor organization and a national “Volunteer of the Year” award from Notre Dame University. In 2006 the International Society of Orthomolecular Medicine named him “Doctor Of The Year”.
How to Get There